Human papillomavirusinfection and vaccination: Knowledge and attitudes of Italian general practitioners;Infezione da Papillomavirusumano e vaccinazione: Conoscenze e ruolo dei medici di medicina generale

Epidemiologia e Prevenzione

Volumn 38, Issue 6, 2014, Pages 88-92

  Signorelli, Carlo ^a   Odone, Anna ^a   Pezzetti, Federica ^a   Spagnoli, Francesca ^a   Visciarelli, Sara ^a   Ferrari, Antonio ^a   Camia, Paola ^a   Latini, Chiara ^a   Ciorba, Veronica ^a   Agodi, Antonella ^b   Barchitta, Martina ^b   Scotti, Silvestro ^c   Misericordia, Paolo ^c   Pasquarella, Cesira ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c Federazione Italiana Medici di Medicina Generale (FIMMG)   (Italy)

Author keywords

General practitioners; Human papillomavirus; Knowledge; Vaccination

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE; ANUS NEOPLASMS; ATTITUDE TO HEALTH; CARCINOMA, SQUAMOUS CELL; CONDYLOMATA ACUMINATA; CROSS-SECTIONAL STUDY; FEMALE; GENERAL PRACTITIONER; GENITAL NEOPLASMS, FEMALE; HEALTH CARE SURVEY; HUMAN; ITALY; MALE; MEDICAL EDUCATION; MIDDLE AGED; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PREVENTIVE HEALTH SERVICE; PSYCHOLOGY; SEXUAL BEHAVIOR; TRANSMISSION; TUMOR VIRUS INFECTIONS; VACCINATION; VIROLOGY;

ADULT; AGE FACTORS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CONDYLOMATA ACUMINATA; CROSS-SECTIONAL STUDIES; EDUCATION, MEDICAL, CONTINUING; FEMALE; GENERAL PRACTITIONERS; GENITAL NEOPLASMS, FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION PROGRAMS; ITALY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEXUAL BEHAVIOR; TUMOR VIRUS INFECTIONS; VACCINATION;

EID: 84937574503     PISSN: 11209763     EISSN: 23851937     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Panatto D. Papillomavirus. In: (Gasparini R, Bonanni P, Coppola RC et al eds). Le vaccinazioni. Roma, Società Editrice Universo, 2013:93-7.
2. Bruni L, Diaz M, Castellsague X et al. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 2010;202(12):1789-99.
3. Dochez C, Bogers JJ, Verhelst R, Rees H. HPV vaccines to prevent cervical cancer and genital warts: an update. Vaccine. 2014;32(14):1595-601.
4. Crosignani P, De Stefani A, Fara GM et al. Towards the eradication of HPV infection through universal specific vaccination. BMC public health 2013;13:642.
5. Tota JE, Chevarie-Davis M, Richardson LA et al. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies. Preventive medicine 2011;53 Suppl 1:S12-21.
6. Herweijer E, Leval A, Ploner A et al. Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma. JAMA 2014;311(6):597-603.
7. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11[Internet]. Lyon (France), International Agency for Research on Cancer, 2013. [http://globocan. iarc.fr] (ultimo accesso: ottobre 2014).
8. Giambi C, Del Manso M, De Mei B et al. Progetto VALORE. Rapporti ISTISAN 13/47. Roma, Istituto superiore di sanità, 2013.
9. Il Calendario vaccinale per la vita 2014. Documento di indirizzo. In: Atti del 47° congresso nazionale SItI. Epidemiol Prev 2014;38(6):133-48.
10. Giambi C. Stato di avanzamento della campagna vaccinale per l'HPV: dati di copertura vaccinale al 31/12/2013-rapporto semestrale. Cnesps-ISS.
11. Riedesel JM, Rosenthal SL, Zimet GD et al. Attitudes about human papillomavirus vaccine among family physicians. JPAG 2005;18(6):391-98.
12. La Torre G, De Vito E, Ficarra MG et al. Is there a lack of information on HPV vaccination given by health professionals to young women? Vaccine 2013;31(42):4710-13.
13. Anhang Price R, Koshiol J, Kobrin S, Tiro JA. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine 2011;29(25):4238-43.
14. Brotherton JM, Leask J, Jackson C et al. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program. Sexual health 2010;7(3):291-98.
15. Odone A, Ferrari A, Spagnoli F et al. Effectiveness of interventions that apply new media to improve vaccine uptake and vaccine coverage. Hum Vaccin Immunother 2014:e34313.
16. Harrison C, Britt H, Garland S et al. Decreased Management of Genital Warts in Young Women in Australian General Practice Post Introduction of National HPV Vaccination Program: Results from a Nationally Representative Cross-Sectional General Practice Study. PLoS One 2014;9(9):e105967.
17. Hohwu L, Bro F. Contact from general practitioners to unvaccinated girls can increase HPV vaccination consent. Ugeskr Laeger 2012;174(14):942-45.
18. Lasset C, Kalecinski J, Regnier V et al. Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two crosssectional studies in 2007 and 2010. Int J Public Health 2014;59(3):519-28.
19. Mazza D, Petrovic K, Chakraborty S. HPV vaccination of adult women: an audit of Australian general practitioners. AustNZJObstet Gynaecol 2012;52(6):528-33.
20. Mazza D, Petrovic K, Grech C, Harris N. HPV vaccination in women aged 27 to 45 years: what do general practitioners think? BMC Womens Health 2014;14:91.
21. Berraho M, Fakir SE, Abda N et al. [HPV and cervical cancer: knowledge and practices of physicians in Fez]. Santé Publique 2013;25(3):351-7.
22. Buxton JA, McIntyre CC, Tu AW et al. Who knows more about immunization? Survey of public health nurses and physicians. Can Fam Physician 2013;59(11):e514-21.